Skip to main content
Mijn bibliotheek
Shop
Nieuws
Boeken
Tijdschriften
E-learning
Web-tv
Video
Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

Gepubliceerd in:
Fundamentele aspecten van kanker hoofdstuk lezen eerste hoofdstuk lezen

2017 | OriginalPaper | Hoofdstuk

30. Endocriene tumoren

Auteurs : A. M. Pereira Arias, J. W. A. Smit, J. Kievit, E. Kapiteijn, P. T. A. M. Lips, C. J. Lips, H. R. Haak, E. P. M. van der Kleij-Corssmit, O. M. Dekkers, R. A. Feelders, N. R. Biermasz, W. de Herder, H. F. ten Kroode, Th. P. Links

Gepubliceerd in: Leerboek oncologie

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

De endocriene oncologie betreft een uitgebreid vakgebied, waarbij behalve de endocrinologie en oncologie andere disciplines, zoals de klinische farmacologie, heelkunde, pathologie, genetica en moleculaire biologie nauw zijn betrokken. Tumoren van endocriene cellen worden symptomatisch gekenmerkt door overproductie van hormonen of door massa-effect van de tumor, bijvoorbeeld een niet-functionerende hypofysetumor. Soms zijn er weinig klachten, zoals bij metastasering van schildkliercarcinoom. Veel tumoren produceren ectopisch hormonen, waardoor specifieke klinische beelden kunnen ontstaan.
vorige hoofdstuk Tumoren van het zenuwstelsel
volgende hoofdstuk Tumoren van de oogleden, ogen en orbita
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
Gimenez-Roqueplo AP, Dahia PL, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res. 2012;44:328–33. CrossRefPubMed
Haller F, et al. Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad. Endocr Relat Cancer 2014 May 23;21(4):567–77. CrossRefPubMedPubMedCentral
Krampitz GW, Norton JA. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Cancer 2014;120(13):1920–31. CrossRefPubMed
Mester J, Eng C. When overgrowth bumps into cancer: the PTEN-Opathies. Am J Med Genet C Semin Med Genet. 2013;163C(2):114–21. CrossRefPubMed
Northrup H, Krueger DA. International tuberous sclerosis complex consensus group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):243–54. CrossRefPubMedPubMedCentral
Rodriguez FJ, Stratakis CA, Evans DG. Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathol. 2012; 123: 349–67.
Staser K1, Yang FC, Clapp DW. Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression. Annu Rev Pathol. 2012;7:469–95.
Wadt KA, Gerdes AM, Hansen TV, Toft BG, Friis-Hansen L, Andersen MK. Novel germline c-MET mutation in a family with hereditary papillary renal carcinoma. Fam Cancer 2012;11(3):535–7. CrossRefPubMed
Wang O, Wang C, Nie M, Cui Q, Guan H, Jiang Y, Li M, Xia W, Meng X, Xing X. Novel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas. PLoS One 2012;7(9):e45567.
Zhang L, Smyrk TC, Young WF Jr, Stratakis CA, Carney JA. Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am J Surg Pathol. 2010;34(1):53–64.
Barrisford GW, Singer EA, Rosner IL, Linehan WM, Bratslavsky G. Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol. 2011;2011:658767.
Baysal BE, Maher ER. 15 years of paraganglioma: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations. Endocr Relat Cancer. 2015;22(4):T71–82.
Benn DE, Robinson BG, Clifton-Bligh RJ. 15 years of paraganglioma: Clinical manifestations of paraganglioma syndromes types 1-5. Endocr Relat Cancer. 2015;22(4):T91–103.
Blakeley JO, Plotkin SR. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro Oncol. 2016;18(5):624–38.
Caban C, Khan N, Hasbani DM, Crino PB. Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet. 2016 Dec 21;10:1–8.
Canaff L, Vanbellinghen JF, Kanazawa I, Kwak H, Garfield N, Vautour L, Hendy GN. Menin missense mutants encoded by the MEN1 gene that are targeted to the proteasome: restoration of expression and activity by CHIP siRNA. J Clin Endocrinol Metab. 2012;97(2):E282–91.
Gammon A, Jasperson K, Champine M. Genetic basis of Cowden syndrome and its implications for clinical practice and risk management. Appl Clin Genet. 2016 Jul 13;9:83–92.
Helfferich J, Nijmeijer R, Brouwer OF, Boon M, Fock A, Hoving EW, Meijer L, den Dunnen WF, Bont ES de. Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas. Crit Rev Oncol Hematol. 2016;104:30–41.
Kingswood JC, Bissler JJ, Budde K, Hulbert J, Guay-Woodford L, Sampson JR, Sauter M, Cox J, Patel U, Elmslie F, Anderson C, Zonnenberg BA. Review of the Tuberous Sclerosis Renal Guidelines from the 2012 Consensus Conference: Current Data and Future Study. Nephron. 2016;134(2):51–8.
Kresak JL, Walsh M. Neurofibromatosis: A Review of NF1, NF2, and Schwannomatosis. J Pediatr Genet. 2016;5(2):98–104.
Lam HC, Nijmeh J, Henske EP. New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex. J Pathol. 2017;241(2):219–25.
Mori H1, Yao Y1, Learman BS1, Kurozumi K2, Ishida J2, Ramakrishnan SK1, Overmyer KA1, Xue X1, Cawthorn WP1,3, Reid MA1, Taylor M1, Ning X1,4, Shah YM1,5, MacDougald OA1,5. Induction of WNT11 by hypoxia and hypoxia-inducible factor-1α regulates cell proliferation, migration and invasion. Sci Rep. 2016 Feb 10;6:21520.
Ospina NS, Donegan D, Rodriguez-Gutierrez R, Al-Hilli Z, Young WF Jr. Assessing for multiple endocrine neoplasia type 1 in patients evaluated for Zollinger-Ellison Syndrome - clues to a safer diagnostic process. Am J Med. 2016 Dec 20.
Preez H du, Adams A, Richards P, Whitley S. Hyperparathyroidism jaw tumour syndrome: a pictoral review. Insights Imaging. 2016;7(6):793–800.
Schödel J1, Grampp S2, Maher ER3, Moch H4, Ratcliffe PJ5, Russo P6, Mole DR5. Hypoxia, hypoxia-inducible transcription factors, and renal cancer. Eur Urol. 2016;69(4):646–57.
Stratakis CA. Carney complex: A familial lentiginosis predisposing to a variety of tumors. Rev Endocr Metab Disord. 2016;17(3):367–71.
Talarico C1, Dattilo V, D'Antona L, Menniti M, Bianco C, Ortuso F, Alcaro S, Schenone S, Perrotti N, Amato R. SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition. Cell Physiol Biochem. 2016;39(5):1863–76.
Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567–610. https://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​25810047
Wilson TA, Rodgers S, Tanweer O, Agarwal P, Lieber BA, Agarwal N, McDowell M, Devinsky O, Weiner H, Harter DH. Tuberous Sclerosis Health Care Utilization Based on the National Inpatient Sample Database: A Review of 5655 Hospitalizations. World Neurosurg. 2016;91:97–105.
Wimmer K, Rosenbaum T, Messiaen L. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1. Clin Genet. 2016 Oct 25.
Metagegevens
Titel
Endocriene tumoren
Auteurs
A. M. Pereira Arias
J. W. A. Smit
J. Kievit
E. Kapiteijn
P. T. A. M. Lips
C. J. Lips
H. R. Haak
E. P. M. van der Kleij-Corssmit
O. M. Dekkers
R. A. Feelders
N. R. Biermasz
W. de Herder
H. F. ten Kroode
Th. P. Links
Copyright
2017
Uitgeverij
Bohn Stafleu van Loghum
Boek
Leerboek oncologie

Print ISBN: 978-90-368-0441-7

Elektronisch ISBN: 978-90-368-0442-4

Copyright: 2017

DOI
https://doi.org/10.1007/978-90-368-0442-4_30